Asia Pacific Vaccines Market 2027 By Technology, Disease Indication, Route of Administration, Patient Type, and Country | The Insight Partners
The Asia Pacific human vaccines market is expected to reach US$ 12,631.4 Mn in 2027 from US$ 7,254.5 Mn in 2018. The market is estimated to grow with a CAGR of 6.4% from 2019-2027.
The growth of the market is driven by the factors such as rising number of awareness programs, campaigns and conferences for vaccination in Asia Pacific and growing vaccine production in Asia Pacific are likely to grow the vaccines market in the forecast period. Whereas, the mistrust on immunization in the Asia Pacific region is likely to impact the growth of the vaccines market during the forecast period.
Every year thousands of children in Asia Pacific region die, and many more are hospitalized due to diseases which are preventable by vaccines. The treatment cost of these diseases is very high. According to the Gavi, the Vaccine Alliance, one in every five children in Asia Pacific region don’t have access to basic vaccines. Thus in Asia Pacific region, many awareness programs have been undertaken by the government in order to raise awareness among the population. The Immunization Partners in Asia Pacific (IPAP) arranged the 6th Asian Vaccine Conference (ASVAC 2017), in April 2017at Singapore.
The countries in the Asia Pacific region are joining forces to eradicate infectious diseases like measles, diphtheria, rubella, pertussis, and others through vaccinations. There are several vaccination programs, campaigns, conferences, being held in the Asia Pacific region in order to raise awareness among the population. For instance, India, along with other WHO South East Asia Region member countries, has initiated a campaign to eradicate measles and control rubella/congenital rubella syndrome (CRS) by 2020. The campaigns by the Ministry of Health & Family Welfare aims to immunize 41 crore children in India. The first phase of the campaign was successfully completed in February 2017 in five states, namely, Tamil Nadu, Karnataka, Goa, Lakshadweep, and Puducherry. Over 3.3 crore children were vaccinated, reaching out to 97% of the targeted age group. The campaign was conducted in schools, community centers, and other health facilities.
Japan is expected to lead the market in the Asia Pacific region due to the presence of major market players, government grants for vaccine research, and the country has strong and growing vaccination programs across the country. The development of the preventive vaccination for various diseases is likely to drive the market for vaccination in the country. Therefore, considering the above mentioned factors, the growth of the market in the country is likely to contribute the largest share in the Asia Pacific region during the forecast period.
Rest of Asia Pacific Vaccines Market Revenue and Forecasts to 2027 ( US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC VACCINES– MARKET SEGMENTATION
By Technology
- Recombinant vaccines
- Conjugate Vaccines
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
ASIA PACIFIC VACCINES – MARKET SEGMENTATION
By Disease Indication
- DTP (diphtheria, tetanus, and pertussis)
- Influenza
- Hepatitis
- Other Diseases
ASIA PACIFIC VACCINES – MARKET SEGMENTATION
By Rout of Administration
- Oral
- Injectable
- Other
ASIA PACIFIC VACCINES – MARKET SEGMENTATION
By Patient Type
- Adults
- Pediatric
By Country
- China
- Japan
- India
- Australia
- South Korea
Companies Mentioned
- PFIZER INC
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Sanofi
- Johnson & Johnson Services, Inc
- Panacea Biotec Limited
- Astellas Pharma Inc.
- NOVAVAX, INC.
- VBI Vaccines Inc
- Bavarian Nordic
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Disease Indication, Route of Administration, Patient Type, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
PART 1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. aSIA paCIFIC Vaccines Market – Key takeaways
PART 3. Asia Pacific Vaccines market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Asia Pacific Vaccines Market – By Technology
3.2.2 Asia Pacific Market – By Disease Indication
3.2.3 Asia Pacific Vaccines Market – By Route of Administration
3.2.4 Asia Pacific Vaccines Market – By Patient Type
3.2.5 Asia Pacific Vaccines Market – By Country
3.3 PEST Analysis
3.3.1 Asia Pacific– PEST Analysis
PART 4. Asia Pacific VAccines market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rising Number of Awareness Programs, Campaigns and Conferences for Vaccination in Asia Pacific
4.1.2 Growing Vaccine Production in Asia Pacific.
4.2 Key Market Restraints
4.2.1 Mistrust of Immunization in the Asia Pacific Region.
4.3 Key Market Opportunities
4.3.1 Increasing Incidences of Infectious and Contagious Diseases
4.4 future Trends
4.4.1 Vaccine Research in Asia
4.5 Impact analysis
PART 5. VAccines market – Asia Pacific Analysis
5.1 Asia Pacific Vaccines market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
5.3.1 GlaxoSmithKline plc
PART 6. Asia Pacific vaccines market Analysis – By TEchnology
6.1 Overview
6.2 ASIA PACIFIC vaccines MARKET, BY Type, 2018 & 2027 (%)
6.3 Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
6.4 Asia Pacific Recombinant Vaccines Market
6.4.1 Overview
6.4.2 Asia Pacific Recombinant Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.5 Asia Pacific Conjugate Vaccines Market
6.5.1 Overview
6.5.2 Asia Pacific Conjugate Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.6 Asia Pacific Live Attenuated Vaccines Market
6.6.1 Overview
6.6.2 Asia Pacific Live Attenuated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.7 Asia Pacific Inactivated Vaccines Market
6.7.1 Overview
6.7.2 Asia Pacific Inactivated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
6.8 Asia Pacific toxoid Vaccines Market
6.8.1 Overview
6.8.2 Asia Pacific Toxoid Vaccines Market Revenue and Forecast to 2027 (US$ Mn)
PART 7. Asia Pacific Vaccines market Analysis – By Disease Indication
7.1 Overview
7.2 ASIA PACIFIC vaccines MARKET, BY disease indication, 2018 & 2027 (%)
7.3 Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
7.4 Asia Pacific DTP (diphtheria, tetanus, and pertussis) Market
7.4.1 Overview
7.4.2 Asia Pacific DTP (Diphtheria, Tetanus, And Pertussis) Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Asia Pacific Influenza Market
7.5.1 Overview
7.5.2 Asia Pacific Influenza Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Asia Pacific Hepatitis Market
7.6.1 Overview
7.6.2 Asia Pacific Hepatitis Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Asia Pacific Other Diseases Market
7.7.1 Overview
7.7.2 Asia Pacific Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)
PART 8. Asia Pacific Vaccines market Analysis – By Route of administration
8.1 Overview
8.2 ASIA PACIFIC Vaccines MARKET, BY route of administration, 2018 & 2027 (%)
8.3 Asia Pacific Vaccines market Revenue And Forecasts to 2027, By route of administration (US$ Mn)
8.4 Asia Pacific Oral Market
8.4.1 Overview
8.4.2 Asia Pacific Oral Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Asia Pacific Injectable Market
8.5.1 Overview
8.5.2 Asia Pacific Injectable Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Asia Pacific Other Routes of Administration Market
8.6.1 Overview
8.6.2 Asia Pacific Other Routes of Administration Market Revenue and Forecast to 2027 (US$ Mn)
PART 9. Asia Pacific Vaccines market Analysis – By Patient type
9.1 Overview
9.2 ASIA PACIFIC Vaccines MARKET, BY patient type, 2018 & 2027 (%)
9.3 Asia Pacific Vaccines market Revenue And Forecasts to 2027, By patient type (US$ Mn)
9.4 Asia Pacific pediatric Market
9.4.1 Overview
9.4.2 Asia Pacific Pediatric Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Asia Pacific adults Market
9.5.1 Overview
9.5.2 Asia Pacific Adults Market Revenue and Forecast to 2027 (US$ Mn)
PART 10. Asia Pacific Vaccines market Revenue and Forecasts to 2027
10.1.1 Overview
10.1.2 Asia Pacific Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.3 Asia Pacific Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.4 Asia Pacific Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.5 Asia Pacific Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.6 Asia Pacific Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.7 Asia Pacific Vaccines Market Revenue and Forecasts to 2027, By Country (%)
10.1.8 China Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9 China Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.1 China Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.9.2 China Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.9.3 China Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.9.4 China Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.10 Japan Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.11 Japan Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.11.1 Japan Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.11.2 Japan Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.11.3 Japan Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.11.4 Japan Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.12 India Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.13 India Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.13.1 India Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.13.2 India Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.13.3 India Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.13.4 India Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.14 Australia Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.15 Australia Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.15.1 Australia Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.15.2 Australia Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.15.3 Australia Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.15.4 Australia Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
10.1.16 South Korea Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.17 South Korea Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.17.1 South Korea Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
10.1.17.2 South Korea Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
10.1.17.3 South Korea Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
10.1.17.4 South Korea Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
PART 11. Vaccines Market–Key company profiles
11.1 PFIZER INC.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 GlaxoSmithKline plc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Merck & Co., Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Sanofi
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Information
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Johnson & Johnson Services, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Panacea Biotec Limited
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Astellas Pharma Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 Swot Analysis
11.7.6 Key Developments
11.8 NOVAVAX, INC.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Information
11.8.4 Product Pipeline
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 VBI Vaccines Inc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Information
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 BAVARIAN NORDIC
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Information
11.10.4 Product Pipeline
11.10.5 SWOT Analysis
11.10.6 Key Developments
PART 12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
TABLE 1. Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 2. Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 3. Asia Pacific vaccines market Revenue And Forecasts to 2027, By route of administration (US$ Mn)
TABLE 4. Asia Pacific vaccines market Revenue And Forecasts to 2027, By patient type (US$ Mn)
TABLE 5. Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 6. Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 7. Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
TABLE 8. Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
TABLE 9. CHINA Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 10. CHINA Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 11. CHINA Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
TABLE 12. CHINA Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
TABLE 13. JAPAN Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 14. JAPAN Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 15. JAPAN Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
TABLE 16. JAPAN Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
TABLE 17. INDIA Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 18. INDIA Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 19. INDIA Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
TABLE 20. INDIA Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
TABLE 21. AUSTRALIA Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 22. AUSTRALIA Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 23. AUSTRALIA Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
TABLE 24. AUSTRALIA Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
TABLE 25. SOUTH KOREA Vaccines market Revenue And Forecasts to 2027, By Technology (US$ Mn)
TABLE 26. SOUTH KOREA Vaccines market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)
TABLE 27. SOUTH KOREA Vaccines market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)
TABLE 28. SOUTH KOREA Vaccines market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)
TABLE 29. Glossary of Terms, Vaccines market
LIST OF FIGURES
FIGURE 1. Germany Vaccines market, Revenue (US$ Mn), By COuntry 2018 & 2027
FIGURE 2. Asia Pacific Vaccines Market By Type, Market Share (%), 2018
FIGURE 3. Asia Pacific vaccines Market By Disease indication, Market Share (%), 2018
FIGURE 4. Asia Pacific Vaccines Market By route of Administration, Market Share (%), 2018
FIGURE 5. Asia Pacific Vaccines Market By Patient Type, Market Share (%), 2018
FIGURE 6. Vaccines market Segmentation
FIGURE 7. Asia pacific PEST Analysis
FIGURE 8. Vaccines market impact analysis of drivers & Restraints
FIGURE 9. Asia Pacific Vaccines market – Revenue Forecasts and Analysis – 2018- 2027
FIGURE 10. Asia Pacific vaccines market, By Technology, 2018 & 2027 (%)
FIGURE 11. Asia Pacific recombinant vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 12. Asia Pacific conjugate vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 13. Asia Pacific live attenuated vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 14. Asia Pacific inactivated vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 15. Asia Pacific toxoid vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 16. Asia Pacific vaccines market By disease indication, 2017 & 2025 (%)
FIGURE 17. Asia Pacific DTP (diphtheria, tetanus, and pertussis) Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 18. Asia Pacific influenza Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 19. Asia Pacific hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 20. Asia Pacific Other Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 21. Asia Pacific vaccines market By route of administration, 2018 & 2027 (%)
FIGURE 22. Asia Pacific oral Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 23. Asia Pacific injectable Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 24. Asia Pacific other routes of administration Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 25. Asia Pacific vaccines market By patient type, 2018 & 2027 (%)
FIGURE 26. Asia Pacific pediatric Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 27. Asia Pacific adults Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 28. Asia Pacific Vaccines market revenue Overview, by Country (2018) (us $ mn)
FIGURE 29. Asia Pacific Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 30. Asia Pacific Vaccines market Revenue And Forecasts to 2027, By Country (%)
FIGURE 31. China Vaccines market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 32. Japan Vaccines market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 33. India Vaccines market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 34. Australia Vaccines market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 35. South Korea Vaccines market Revenue and Forecasts to 2027 (US$ Mn)
The List of Companies - Asia Pacific Vaccines Market
- PFIZER INC
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Sanofi
- Johnson & Johnson Services, Inc
- Panacea Biotec Limited
- Astellas Pharma Inc.
- NOVAVAX, INC.
- VBI Vaccines Inc
- Bavarian Nordic
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For